| 1 | JAK2, MPD
|
| JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.
|
| Jones AV, Chase A, Silver RT, Oscier D, Zoi K, Wang YL, Cario H, Pahl HL, Collins A, Reiter A, Grand F, Cross NC.
|
| Nat Genet 41(4):446-9. Epub 2009 Mar 15.
2009
|
| 2 | JAK2, MPD
|
| A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
|
| Kilpivaara O, Mukherjee S, Schram AM, Wadleigh M, Mullally A, Ebert BL, Bass A, Marubayashi S, Heguy A, Garcia-Manero G, Kantarjian H, Offit K, Stone RM, Gilliland DG, Klein RJ, Levine RL.
|
| Nat Genet 41(4):455-9. Epub 2009 Mar 15.
2009
|
| 3 | JAK2, MPD
|
| A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.
|
| Olcaydu D, Harutyunyan A, Jäger R, Berg T, Gisslinger B, Pabinger I, Gisslinger H, Kralovics R.
|
| Nat Genet 41(4):450-4. Epub 2009 Mar 15.
2009
|
| 4 | JAK2, MPD, MPL, PRV
|
| JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.
|
| Kilpivaara O, Levine RL.
|
| Leukemia 22(10):1813-7. Epub 2008 Aug 28. Review. 2008
|
| 5 | JAK2, MPD, PML, PRV
|
| Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy.
|
| Tefferi A.
|
| Am J Hematol 83(6):491-7. Review. 2008
|
| 6 | JAK2, MPD, MPL
|
| Myeloproliferative disorders.
|
| Levine RL, Gilliland DG.
|
| Blood 112(6):2190-8. Review. 2008
|
| 7 | JAK2, JAK3, MPD, MPL
|
| JAK and MPL mutations in myeloid malignancies.
|
| Tefferi A.
|
| Leuk Lymphoma 49(3):388-97. Review. 2008
|
| 8 | JAK2, MPD, PRV
|
| JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
|
| Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR.
|
| N Engl J Med 356(5):459-68. 2007
|
| 9 | JAK2, MPD
|
| Jak2: normal function and role in hematopoietic disorders.
|
| Ihle JN, Gilliland DG.
|
| Curr Opin Genet Dev 17(1):8-14. Epub 2007 Jan 8. 2007
|
| 10 | JAK2, MPD
|
| The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.
|
| Jamieson CH, Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M, Jones C, Zehnder JL, Lilleberg SL, Weissman IL.
|
| Proc Natl Acad Sci U S A 103(16):6224-9. Epub 2006 Apr 7. 2006
|
| 11 | JAK2, MPD
|
| A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
|
| James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W.
|
| Nature 434(7037):1144-8. 2005
|
| 12 | JAK2, MPD
|
| A gain-of-function mutation of JAK2 in myeloproliferative disorders.
|
| Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC.
|
| N Engl J Med 352(17):1779-90. 2005
|